Skip to main content

Main menu

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • Podcasts
    • Subject Collections
    • Archives
    • Kidney Week Abstracts
    • Saved Searches
  • Authors
    • Submit a Manuscript
    • Author Resources
  • Trainees
    • Peer Review Program
    • Prize Competition
  • About CJASN
    • About CJASN
    • Editorial Team
    • CJASN Impact
    • CJASN Recognitions
  • More
    • Alerts
    • Advertising
    • Feedback
    • Reprint Information
    • Subscriptions
  • ASN Kidney News
  • Other
    • ASN Publications
    • JASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
American Society of Nephrology
  • Other
    • ASN Publications
    • JASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Advertisement
American Society of Nephrology

Advanced Search

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • Podcasts
    • Subject Collections
    • Archives
    • Kidney Week Abstracts
    • Saved Searches
  • Authors
    • Submit a Manuscript
    • Author Resources
  • Trainees
    • Peer Review Program
    • Prize Competition
  • About CJASN
    • About CJASN
    • Editorial Team
    • CJASN Impact
    • CJASN Recognitions
  • More
    • Alerts
    • Advertising
    • Feedback
    • Reprint Information
    • Subscriptions
  • ASN Kidney News
  • Visit ASN on Facebook
  • Follow CJASN on Twitter
  • CJASN RSS
  • Community Forum

chronic renal insufficiency

  • You have accessRestricted Access
    Can Novel Potassium Binders Liberate People with Chronic Kidney Disease from the Low-Potassium Diet?
    David E. St-Jules, Deborah J. Clegg, Biff F. Palmer and Juan-Jesus Carrero
    CJASN March 2022, 17 (3) 467-472; DOI: https://doi.org/10.2215/CJN.09660721
    Add to Selected Citations
  • Association of Polypharmacy with Kidney Disease Progression in Adults with CKD
    You have accessRestricted Access
    Association of Polypharmacy with Kidney Disease Progression in Adults with CKD
    Hiroshi Kimura, Kenichi Tanaka, Hirotaka Saito, Tsuyoshi Iwasaki, Akira Oda, Shuhei Watanabe, Makoto Kanno, Michio Shimabukuro, Koichi Asahi, Tsuyoshi Watanabe and Junichiro James Kazama
    CJASN December 2021, 16 (12) 1797-1804; DOI: https://doi.org/10.2215/CJN.03940321
    Add to Selected Citations
  • Open Access
    Patiromer to Enable Spironolactone in Patients with Resistant Hypertension and CKD (AMBER)
    Rajiv Agarwal, Patrick Rossignol, Martha R. Mayo, Ansgar Conrad, Susan Arthur, Bryan Williams and William B. White
    CJASN September 2021, 16 (9) 1407-1409; DOI: https://doi.org/10.2215/CJN.02890221
    Add to Selected Citations
  • You have accessRestricted Access
    Updates in Diagnosis and Management of Preeclampsia in Women with CKD
    Kate Wiles, Lucy C. Chappell, Liz Lightstone and Kate Bramham
    CJASN September 2020, 15 (9) 1371-1380; DOI: https://doi.org/10.2215/CJN.15121219
    Add to Selected Citations
  • Open Access
    Mineralocorticoid Receptor Antagonists in ESKD
    Adhish Agarwal and Alfred K. Cheung
    CJASN July 2020, 15 (7) 1047-1049; DOI: https://doi.org/10.2215/CJN.13221019
    Add to Selected Citations
  • Open Access
    EHR-Based Clinical Trials
    Khaled Abdel-Kader and Manisha Jhamb
    CJASN July 2020, 15 (7) 1050-1052; DOI: https://doi.org/10.2215/CJN.11860919
    Add to Selected Citations
  • Open Access
    SONAR
    Michael Walsh
    CJASN June 2020, 15 (6) 889-891; DOI: https://doi.org/10.2215/CJN.08540719
    Add to Selected Citations
  • You have accessRestricted Access
    Benefits of Continuing RAAS Inhibitors in Advanced CKD
    Marie-Michèle Gaudreault-Tremblay and Bethany J. Foster
    CJASN May 2020, 15 (5) 592-593; DOI: https://doi.org/10.2215/CJN.02920320
    Add to Selected Citations
  • Association of 24-Hour Ambulatory Blood Pressure Patterns with Cognitive Function and Physical Functioning in CKD
    You have accessRestricted Access
    Association of 24-Hour Ambulatory Blood Pressure Patterns with Cognitive Function and Physical Functioning in CKD
    Lama Ghazi, Kristine Yaffe, Manjula K. Tamura, Mahboob Rahman, Chi-yuan Hsu, Amanda H. Anderson, Jordana B. Cohen, Michael J. Fischer, Edgar R. Miller, Sankar D. Navaneethan, Jiang He, Matthew R. Weir, Raymond R. Townsend, Debbie L. Cohen, Harold I. Feldman, Paul E. Drawz and the CRIC Study Investigators
    CJASN April 2020, 15 (4) 455-464; DOI: https://doi.org/10.2215/CJN.10570919
    Add to Selected Citations
  • Safety of Liraglutide in Type 2 Diabetes and Chronic Kidney Disease
    You have accessRestricted Access
    Safety of Liraglutide in Type 2 Diabetes and Chronic Kidney Disease
    Johannes F.E. Mann, Vivian A. Fonseca, Neil R. Poulter, Itamar Raz, Thomas Idorn, Søren Rasmussen, Bernt Johan von Scholten, Ofri Mosenzon and on behalf of the LEADER Trial Investigators
    CJASN April 2020, 15 (4) 465-473; DOI: https://doi.org/10.2215/CJN.11881019
    Add to Selected Citations

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7

Articles

  • Current Issue
  • Early Access
  • Subject Collections
  • Article Archive
  • ASN Meeting Abstracts

Information for Authors

  • Submit a Manuscript
  • Trainee of the Year
  • Author Resources
  • ASN Journal Policies
  • Reuse/Reprint Policy

About

  • CJASN
  • ASN
  • ASN Journals
  • ASN Kidney News

Journal Information

  • About CJASN
  • CJASN Email Alerts
  • CJASN Key Impact Information
  • CJASN Podcasts
  • CJASN RSS Feeds
  • Editorial Board

More Information

  • Advertise
  • ASN Podcasts
  • ASN Publications
  • Become an ASN Member
  • Feedback
  • Follow on Twitter
  • Subscribe to ASN Journals
  • Wolters Kluwer Partnership

© 2022 American Society of Nephrology

Print ISSN - 1555-9041 Online ISSN - 1555-905X

Powered by HighWire